Peritoneal Dialysis of Three-Cuff Catheter Experience in Qassim Province, Saudi Arabia.

IF 1.7 Q3 UROLOGY & NEPHROLOGY International Journal of Nephrology Pub Date : 2024-10-30 eCollection Date: 2024-01-01 DOI:10.1155/2024/5554703
Ahmed AlSalloom, Chandra Sekhar Kalevaru, Kholoud Alomeri, Sultan Alsayegh
{"title":"Peritoneal Dialysis of Three-Cuff Catheter Experience in Qassim Province, Saudi Arabia.","authors":"Ahmed AlSalloom, Chandra Sekhar Kalevaru, Kholoud Alomeri, Sultan Alsayegh","doi":"10.1155/2024/5554703","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The global rise in noncommunicable diseases, including chronic kidney diseases (CKDs), has led to a significant increase in the use of dialysis units to enhance patient longevity and quality of life. Over time, two-cuff catheters have been replaced by three-cuff catheters, with their usage expanding in nephrology centers across Saudi Arabia. This study aimed to evaluate the benefits, complications, and duration of therapy associated with three-cuff catheters in peritoneal dialysis (PD) patients. <b>Methodology:</b> To ensure the reliability of our results, we conducted a comprehensive cross-sectional study involving 257 patients who underwent three-cuff PD catheter (PDC) insertion and omentopexy. Data were retrospectively collected from 2016 to 2023 at King Fahad Specialist Hospital, Buraidah. The questionnaire was designed based on available variables in the records section and validated by subject experts and experienced research faculty. Data were then entered and analyzed using SPSS version 21.0. Descriptive statistics were employed for inferential statistics, while the chi-square test and logistic regression analysis were used to identify predictors of PD outcomes. <b>Results:</b> The average duration of therapy was 27.84 months, with a standard deviation of 27.23 months. Early complications were minimal, with just 5.1% (<i>n</i> = 13) experiencing peritonitis, 0.8% (<i>n</i> = 2) facing catheter migration, and 0.4% (<i>n</i> = 1 each) encountering omental wrap and exit site infection (ESI) within 30 days of catheter insertion. Remarkably, only 7.8% (<i>n</i> = 20) required catheter reinsertion. In addition, catheter removal due to catheter-related issues was low, affecting only 3.8% of patients. <b>Conclusions:</b> According to the study findings, three-cuff catheters exhibited fewer complications, superior performance, and longer therapy duration. These outcomes may be attributed to the thorough design of the three-cuff catheters, the dedication of the staff, and the implementation of strict policies. To maintain these positive results, it is crucial for the Ministry of Health and the Health Cluster to adopt long-term supportive measures.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2024 ","pages":"5554703"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540897/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/5554703","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The global rise in noncommunicable diseases, including chronic kidney diseases (CKDs), has led to a significant increase in the use of dialysis units to enhance patient longevity and quality of life. Over time, two-cuff catheters have been replaced by three-cuff catheters, with their usage expanding in nephrology centers across Saudi Arabia. This study aimed to evaluate the benefits, complications, and duration of therapy associated with three-cuff catheters in peritoneal dialysis (PD) patients. Methodology: To ensure the reliability of our results, we conducted a comprehensive cross-sectional study involving 257 patients who underwent three-cuff PD catheter (PDC) insertion and omentopexy. Data were retrospectively collected from 2016 to 2023 at King Fahad Specialist Hospital, Buraidah. The questionnaire was designed based on available variables in the records section and validated by subject experts and experienced research faculty. Data were then entered and analyzed using SPSS version 21.0. Descriptive statistics were employed for inferential statistics, while the chi-square test and logistic regression analysis were used to identify predictors of PD outcomes. Results: The average duration of therapy was 27.84 months, with a standard deviation of 27.23 months. Early complications were minimal, with just 5.1% (n = 13) experiencing peritonitis, 0.8% (n = 2) facing catheter migration, and 0.4% (n = 1 each) encountering omental wrap and exit site infection (ESI) within 30 days of catheter insertion. Remarkably, only 7.8% (n = 20) required catheter reinsertion. In addition, catheter removal due to catheter-related issues was low, affecting only 3.8% of patients. Conclusions: According to the study findings, three-cuff catheters exhibited fewer complications, superior performance, and longer therapy duration. These outcomes may be attributed to the thorough design of the three-cuff catheters, the dedication of the staff, and the implementation of strict policies. To maintain these positive results, it is crucial for the Ministry of Health and the Health Cluster to adopt long-term supportive measures.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
沙特阿拉伯卡西姆省使用三袖带导管进行腹膜透析的经验。
背景:包括慢性肾脏疾病(CKD)在内的非传染性疾病在全球呈上升趋势,这导致透析设备的使用大幅增加,以延长患者的寿命并提高生活质量。随着时间的推移,双袖带导管已被三袖带导管所取代,其使用范围在沙特阿拉伯的肾病中心不断扩大。本研究旨在评估腹膜透析(PD)患者使用三袖口导管的好处、并发症和治疗时间。研究方法:为确保研究结果的可靠性,我们开展了一项全面的横断面研究,涉及 257 名接受了三袖口腹膜透析导管(PDC)插入术和网膜切除术的患者。我们回顾性地收集了 2016 年至 2023 年期间布赖达法哈德国王专科医院的数据。问卷根据记录部分的可用变量进行设计,并由学科专家和经验丰富的研究教师进行验证。然后使用 SPSS 21.0 版对数据进行输入和分析。推论性统计采用描述性统计,而 PD 结果的预测因素则采用卡方检验和逻辑回归分析。结果平均疗程为 27.84 个月,标准差为 27.23 个月。早期并发症极少,仅有 5.1%(n = 13)的患者在插入导管后 30 天内出现腹膜炎,0.8%(n = 2)的患者出现导管移位,0.4%(n = 1)的患者出现网膜包裹和出口部位感染(ESI)。值得注意的是,只有 7.8%(20 人)需要重新插入导管。此外,因导管相关问题而拔除导管的患者很少,仅占 3.8%。结论:研究结果表明,三拷贝导管并发症少、性能优越、治疗时间长。这些结果可能归功于三拷贝导管的周密设计、工作人员的敬业精神以及严格的政策执行。为了保持这些积极成果,卫生部和卫生组必须采取长期的支持措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Nephrology
International Journal of Nephrology UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
4.80%
发文量
44
审稿时长
17 weeks
期刊介绍: International Journal of Nephrology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focusing on the prevention, diagnosis, and management of kidney diseases and associated disorders. The journal welcomes submissions related to cell biology, developmental biology, genetics, immunology, pathology, pathophysiology of renal disease and progression, clinical nephrology, dialysis, and transplantation.
期刊最新文献
Chronic Kidney Disease: Decreasing Serum Klotho Levels Predict Adverse Renal and Vascular Outcomes. Urinary Nephrin: A Potential Biomarker of Early Glomerular Injury in a Cohort of Pregnant Women Attending Routine Antenatal Care Services. Peritoneal Dialysis of Three-Cuff Catheter Experience in Qassim Province, Saudi Arabia. The Protective Activity of Withania somnifera Against Mercuric Chloride (HgCl2)-Induced Renal Toxicity in Male Rats. Key Performance Indicators of Secondary Health Care in Chronic Kidney Disease: Experience in Public and Private Services in the State of São Paulo, Brazil.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1